US · Healthcare · Medical Devices
EPS came in at -0.48 against a street estimate of -0.50 — a beat of 4.0%.
Analysts rate CeriBell, Inc a strong buy (8 buy, 0 hold, 0 sell out of 8) with an average price target of $29.57.
| Fund | Stake |
|---|---|
| FMR Inc | 14.83% |
| TPG GP A, LLC | 9.80% |
| Red Tree Management, LLC | 5.75% |
| BlackRock Inc | 5.04% |
| Vanguard Capital Management, LLC | 2.95% |
| KCM Capital Inc | 2.93% |
| Federated Hermes Inc | 2.45% |
| Franklin Templeton Inc | 2.39% |
| Document | Date |
|---|---|
| Quarterly report · Q3 2026 HEADLINE NUMBERS • Third-quarter 2026 revenue was $29,341,000, up from $22,589,000 in the third quarter of 2025. • Nine-month 2026 revenue was $83,9 | 2026-11-03 |
| Results announced · Q4 2026 HEADLINE NUMBERS • Third-quarter 2026 revenue was $29.3 million, up 30% from $22.6 million in the third quarter of 2025. • Product revenue was $22.2 | 2026-11-03 |
| Quarterly report · Q2 2026 CERIBELL, INC. — QUARTERLY REPORT SUMMARY Q2 2026 (Period ended June 30, 2026) --- HEADLINE NUMBERS • Total Revenue (6 months): $54.6 million (up 3 | 2026-08-10 |
| Results announced · Q3 2026 CERIBELL, INC. - Q2 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Total revenue Q2 2026: $28.1 million, up 33% from $21.2 million in Q2 2025 • Product re | 2026-08-10 |
| Board / officer change · Q3 2026 CERIBELL, INC. - 8-K SUMMARY (July 28, 2026) BUSINESS & SEGMENT HIGHLIGHTS • CeriBell, Inc. (ticker: CBLL) is a Nasdaq-listed medical device company | 2026-07-30 |
| Shareholder vote results · Q2 2026 CERIBELL, INC. - 8-K SUMMARY HEADLINE NUMBERS • Annual stockholder meeting held June 2, 2026 • Company trades on Nasdaq Global Select Market under t | 2026-06-02 |
| Quarterly report · Q1 2026 CERIBELL, INC. – Q1 2026 10-Q SUMMARY --- HEADLINE NUMBERS • Total revenue (Q1 2026): $26.5 million, up 29% from $20.5 million in Q1 2025 - Produ | 2026-05-11 |
| Results announced · Q2 2026 CERIBELL, INC. - Q1 2026 FINANCIAL RESULTS SUMMARY HEADLINE NUMBERS • Total revenue Q1 2026: $26.5 million — up 29% from $20.5 million in Q1 2025 • | 2026-05-11 |
Readable in the app.
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for CeriBell, Inc — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-11-07.